Moberg Derma Interim Report January - March 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

Moberg Derma AB (STO:MOB):

FIRST QUARTER (JAN-MAR 2012)

· Revenue MSEK 31.0 (5.5)

· Research and development expenses MSEK 7.9 (6.6)

MORE ON THIS TOPIC